glp-1/gip Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist GLP-1/GIP Tirzepatide Rx | FancyMeds
Description
Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases
Coverage of Lillys obesity medications is expanding in the near future
GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss
Results Reducing dose frequency does not commensurately reduce weight loss
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a class of agents that have evolved rapidly in recent years
